Lorence H. Kim - 08 Sep 2026 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Reporting relationship: Director
Issuer ticker: RVMD
Reported as of: 08 Sep 2026
Net transaction value: -$3,585,837
SEC form: 4
Accepted by SEC: 10 Sep 2026, 17:52:37 UTC
Prior SEC filing: 02 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Jack Anders, as Attorney-in-fact for Lorence H. Kim

Key filing fact

Lorence H. Kim filed Form 4 for Revolution Medicines, Inc. (RVMD) on 10 Sep 2026.

Key facts

This page summarizes Lorence H. Kim's Form 4 filing for Revolution Medicines, Inc. (RVMD).
7 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 10 Sep 2026, 17:52.

Change

Previous filing in this sequence was filed on 02 Sep 2026.
Current net transaction value: -$3,585,837.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001643746 Primary reporting owner

Kim Lorence H.

Relationship: Director
Address: C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY
Signature: /s/ Jack Anders, as Attorney-in-fact for Lorence H. Kim
Signature date: 10 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RVMD transaction

Common Stock

Sale

Transaction value: $145,863
Shares: -706
Change %: -4.1%
Price: $206.60
Shares after: 16,384
Date: 08 Sep 2026
Ownership: Trust
Footnotes: F2, F3, F4

RVMD transaction

Common Stock

Sale

Transaction value: $207,125
Shares: -999
Change %: -6.1%
Price: $207.33
Shares after: 15,385
Date: 08 Sep 2026
Ownership: Trust
Footnotes: F2, F4, F5

RVMD transaction

Common Stock

Sale

Transaction value: $748,081
Shares: -3,587
Change %: -23%
Price: $208.55
Shares after: 11,798
Date: 08 Sep 2026
Ownership: Trust
Footnotes: F2, F4, F6

RVMD transaction

Common Stock

Sale

Transaction value: $597,875
Shares: -2,853
Change %: -24%
Price: $209.56
Shares after: 8,945
Date: 08 Sep 2026
Ownership: Trust
Footnotes: F2, F4, F7

RVMD transaction

Common Stock

Sale

Transaction value: $995,678
Shares: -4,730
Change %: -53%
Price: $210.50
Shares after: 4,215
Date: 08 Sep 2026
Ownership: Trust
Footnotes: F2, F4, F8

RVMD transaction

Common Stock

Sale

Transaction value: $812,463
Shares: -3,844
Change %: -91%
Price: $211.36
Shares after: 371
Date: 08 Sep 2026
Ownership: Trust
Footnotes: F2, F4, F9

RVMD transaction

Common Stock

Sale

Transaction value: $78,752
Shares: -371
Change %: -100%
Price: $212.27
Shares after: 0
Date: 08 Sep 2026
Ownership: Trust
Footnotes: F2, F4, F10

RVMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,191
Date: 08 Sep 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 10 footnotes

Footnote F1

Includes 1,191 restricted stock units.

Footnote F2

Transaction made pursuant to a 10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026.

Footnote F3

The transaction was executed in multiple trades at prices ranging from $206.47 to $206.9903, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F4

Shares held by the Lorence Kim Revocable Trust.

Footnote F5

The transaction was executed in multiple trades at prices ranging from $207.02 to $207.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F6

The transaction was executed in multiple trades at prices ranging from $208.05 to $208.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F7

The transaction was executed in multiple trades at prices ranging from $209.08 to $209.9809, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F8

The transaction was executed in multiple trades at prices ranging from $210.0114 to $210.97, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F9

The transaction was executed in multiple trades at prices ranging from $211.00 to $211.9425, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F10

The transaction was executed in multiple trades at prices ranging from $212.0775 to $212.3903, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.